Market Overview:
The global hydroxychloroquine sulfate market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of autoimmune diseases, rising awareness about the benefits of hydroxychloroquine sulfate, and growing demand for generic drugs. Based on type, the global hydroxychloroquine sulfate market is segmented into USP standards grade, EP standards grade, pharmaceutical standards grade, and others. The USP standards grade segment is expected to account for the largest share of the global hydroxychloroquine sulfate market in 2018. This can be attributed to factors such as increasing demand for high-quality drugs and stringent regulatory requirements in developed countries. Based on application, the global hydroxychloroquine sulfate market is segmented into rheumatoid joint pain, adolescent chronic joint pain (ACJP), discoid lupus erythematosus (DLE), systemic lupus erythematosus (SLE), skin lesions associated with lupus erythematosus (LE), and others. The rheumatoid joint pain segment is expected to account for the largest share of the global hydroxychloroquine sulfate market in 2018.
Product Definition:
Hydroxychloroquine sulfate is a type of medication known as an anti-malarial. It is used to treat and prevent malaria, as well as some other conditions.
USP Standards Grade:
USP stands for United States Pharmacopeia. It is a set of standards developed by the U.S. government for the quality and safety of pharmaceutical products, which are marketed in the country as well as exported to other countries with regulatory approval from USP and its member boards.
EP Standards Grade:
EP standards grade is the standard quality for hydroxychloroquine sulfate. It is a trade name and a specification grade of chloroquine phosphate, which has been widely used as an anti-viral medication since the early 1960s. The active pharmaceutical ingredient (API) was previously known as quinolones; it is now more commonly referred to as EP standards grade or simply HCLS.
Application Insights:
Rheumatoid joint was the largest application segment in terms of revenue share in 2017. Rheumatoid arthritis is a common disorder affecting the joints and occurs more frequently in women than men. It typically affects people aged 30 to 60 years, but it can also occur at a younger age. According to estimates reported by Arthritis Foundation, around 1.5 million people are affected across the U.S., with over 150,000 new cases being diagnosed every year globally (as of 2016). The disease mainly affects large joints such as those between fingers and thumbs, elbows, shoulders and hips among others; smaller joints such as ankles may also be involved however they are less frequent sites for arthritis development compared to larger ones (4).
Regional Analysis:
North America was the largest market for hydroxychloroquine sulfate with a share of over 40.0% in 2017. The region is expected to maintain its dominance during the forecast period on account of increasing R&D investments by manufacturers and rising adoption of innovative products. In addition, high prevalence of rheumatoid arthritis and Lupus is also anticipated to drive regional growth during the forecast period.
Asia Pacific is anticipated to be one of the fastest-growing regions over the forecast years owing to growing healthcare spending, improving economic conditions, expanding patient pool base, and rising awareness about Hydroxychloroquine sulfate tablets brand among patients suffering from arthritic disorders & related symptoms such as joint pain & swelling stiffness in this region especially in India China Indonesia Thailand Malaysia Philippines Singapore South Korea Vietnam Australia New Zealand Japan & Taiwan (PHL).
Growth Factors:
- Increasing prevalence of autoimmune diseases: Hydroxychloroquine sulfate is used to treat a variety of autoimmune diseases, which is expected to drive the market growth.
- Rising awareness about the benefits of hydroxychloroquine sulfate: There is a growing awareness among physicians and patients about the benefits of hydroxychloroquine sulfate, which is likely to boost demand for the drug in the coming years.
- Growing number of clinical studies on hydroxychloroquine sulfate: The number of clinical studies being conducted on hydroxychloroquine sulfate is increasing, which will help in expanding its use across various indications.
- Launch of novel formulations and delivery systems: Pharmaceutical companies are launching novel formulations and delivery systems for hydroxychloroquine sulfate, thereby widening its therapeutic potential. This will spur market growth in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Hydroxychloroquine Sulfate Market Research Report
By Type
USP Standards Grade, EP Standards Grade, Pharmaceutical Standards Grade, Others
By Application
Rheumatoid Joint, Adolescent Chronic Joint, Discoid and Systemic Lupus Erythemato Sus, Skin Lesions
By Companies
Sandoz, TEVA, Mylan, HIKMA, IPCA, Jiangsu Shenhua Pharmaceutical, Sanofi, TAJ Pharma, Shanghai Zhongxisanwei, Wuhan Wuyao Pharmaceutical, Sandoz
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Hydroxychloroquine Sulfate Market Report Segments:
The global Hydroxychloroquine Sulfate market is segmented on the basis of:
Types
USP Standards Grade, EP Standards Grade, Pharmaceutical Standards Grade, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Rheumatoid Joint, Adolescent Chronic Joint, Discoid and Systemic Lupus Erythemato Sus, Skin Lesions
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sandoz
- TEVA
- Mylan
- HIKMA
- IPCA
- Jiangsu Shenhua Pharmaceutical
- Sanofi
- TAJ Pharma
- Shanghai Zhongxisanwei
- Wuhan Wuyao Pharmaceutical
- Sandoz
Highlights of The Hydroxychloroquine Sulfate Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- USP Standards Grade
- EP Standards Grade
- Pharmaceutical Standards Grade
- Others
- By Application:
- Rheumatoid Joint
- Adolescent Chronic Joint
- Discoid and Systemic Lupus Erythemato Sus
- Skin Lesions
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hydroxychloroquine Sulfate Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hydroxychloroquine sulfate is a medication used to treat malaria. It works by stopping the growth of the parasite in the body.
Some of the major players in the hydroxychloroquine sulfate market are Sandoz, TEVA, Mylan, HIKMA, IPCA, Jiangsu Shenhua Pharmaceutical, Sanofi, TAJ Pharma, Shanghai Zhongxisanwei, Wuhan Wuyao Pharmaceutical, Sandoz.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hydroxychloroquine Sulfate Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Hydroxychloroquine Sulfate Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Hydroxychloroquine Sulfate Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Hydroxychloroquine Sulfate Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Hydroxychloroquine Sulfate Market Size & Forecast, 2020-2028
4.5.1 Hydroxychloroquine Sulfate Market Size and Y-o-Y Growth
4.5.2 Hydroxychloroquine Sulfate Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 USP Standards Grade
5.2.2 EP Standards Grade
5.2.3 Pharmaceutical Standards Grade
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Rheumatoid Joint
6.2.2 Adolescent Chronic Joint
6.2.3 Discoid and Systemic Lupus Erythemato Sus
6.2.4 Skin Lesions
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Hydroxychloroquine Sulfate Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Hydroxychloroquine Sulfate Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 USP Standards Grade
9.6.2 EP Standards Grade
9.6.3 Pharmaceutical Standards Grade
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Rheumatoid Joint
9.10.2 Adolescent Chronic Joint
9.10.3 Discoid and Systemic Lupus Erythemato Sus
9.10.4 Skin Lesions
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 USP Standards Grade
10.6.2 EP Standards Grade
10.6.3 Pharmaceutical Standards Grade
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Rheumatoid Joint
10.10.2 Adolescent Chronic Joint
10.10.3 Discoid and Systemic Lupus Erythemato Sus
10.10.4 Skin Lesions
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 USP Standards Grade
11.6.2 EP Standards Grade
11.6.3 Pharmaceutical Standards Grade
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Rheumatoid Joint
11.10.2 Adolescent Chronic Joint
11.10.3 Discoid and Systemic Lupus Erythemato Sus
11.10.4 Skin Lesions
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 USP Standards Grade
12.6.2 EP Standards Grade
12.6.3 Pharmaceutical Standards Grade
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Rheumatoid Joint
12.10.2 Adolescent Chronic Joint
12.10.3 Discoid and Systemic Lupus Erythemato Sus
12.10.4 Skin Lesions
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 USP Standards Grade
13.6.2 EP Standards Grade
13.6.3 Pharmaceutical Standards Grade
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Rheumatoid Joint
13.10.2 Adolescent Chronic Joint
13.10.3 Discoid and Systemic Lupus Erythemato Sus
13.10.4 Skin Lesions
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Hydroxychloroquine Sulfate Market: Competitive Dashboard
14.2 Global Hydroxychloroquine Sulfate Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sandoz
14.3.2 TEVA
14.3.3 Mylan
14.3.4 HIKMA
14.3.5 IPCA
14.3.6 Jiangsu Shenhua Pharmaceutical
14.3.7 Sanofi
14.3.8 TAJ Pharma
14.3.9 Shanghai Zhongxisanwei
14.3.10 Wuhan Wuyao Pharmaceutical
14.3.11 Sandoz
